Skip to content

Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?

Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04470739
Enrollment
20
Registered
2020-07-14
Start date
2020-05-30
Completion date
2020-10-30
Last updated
2020-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Thymic Hypoplasia

Brief summary

COVID-19 infected pregnant women is thought to have variable degrees of inflammatory response against the disease. Investigators of present study, suggested that fetuses are affected from the possible fetal inflammatory syndrome in case of maternal COVID-19. Therefore the aim of his study is to evaluate that if the cardiothymic index is affected by the maternal COVID-19 and to demonstrate any possible association of this measurement with neonatal morbidities.

Detailed description

COVID-19 infected pregnant women is thought to have variable degrees of inflammatory response against the disease. Fetus is known to be influenced by maternal systemic infections. Thymus size of fetus and the neonate, is proven to be changed by primarily inflammatory/infectious diseases. Investigators of present study, suggested that fetuses are affected from the possible fetal inflammatory syndrome in case of maternal COVID-19. Therefore the aim of his study is to evaluate that if the cardiothymic index is affected by the maternal COVID-19 and to demonstrate any possible association of this measurement with neonatal morbidities.

Interventions

DIAGNOSTIC_TESTchest x-ray

First Chest X-ray in the first 6 hours of infants

Sponsors

Kanuni Sultan Suleyman Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 7 Hours
Healthy volunteers
Yes

Inclusion criteria

* Infants born to COVID-19 positive or negative mothers * Accepted to participate with an informed consent * Infants who required to get chest X-ray within the first 6 hours

Exclusion criteria

* Infants whose mothers' have any kind of acute or chronic systemic disease or inflammation/infection * Lack of an informed consent * Infants who did not require to get chest X-ray within the first 6 hours

Design outcomes

Primary

MeasureTime frameDescription
Cardiothymic index4 monthsCardiothymic index will be measured by using the thymic shadow divided by largest diameter of mediastinum in the chest X-ray of those infants.

Secondary

MeasureTime frameDescription
Immune profile6 monthsIn long term follow up of those patients, infants will be evaluated for any kind of immune deficiency or quantitative or qualitative abnormalities of leukocytes

Countries

Turkey (Türkiye)

Contacts

Primary ContactSeda Yilmaz Semerci
sedayilmazsemerci@gmail.com+905337180683

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026